Certified by Founder Lodge
Triumvira Immunologics, Inc.
United States - Austin, Texas
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Triumvira Immunologics, Inc., our team is dedicated to a vision of finding a cure and providing new hope for patients with life-threatening disease.
Co-founded in 2015 by licensing tech
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 17 ,2022 | Series A | $100,000,000 |
B Capital
Northpond Ventures
ATEM Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
